Literature DB >> 11738189

Clinical neurophysiology of ALS.

A Eisen1, M Swash.   

Abstract

The neurophysiology of amyotrophic lateral sclerosis is important not only in relation to diagnosis, but also in the development of methods to follow progress, and the effects of putative therapies, in the disease. Quantitative techniques can be applied to the measurement of reinnervation using needle electromyogram. The methodology of motor unit number estimation may be useful in measuring loss of functioning motor units in groups of patients but variability in the measurement using current methods limits its sensitivity in the evaluation of individual patients. Conventional neurophysiological measurements, expressed as a multimetric index, may be useful in assessing progress. The cortical and upper motor neuron system can be assessed using transcortical magnetic stimulation protocols, and cortical excitability may be measured by the peristimulus histogram method. In this review the advantages, limitations and promise of these various methods is discussed, in order to indicate the direction for further neurophysiological studies in this disorder.

Entities:  

Mesh:

Year:  2001        PMID: 11738189     DOI: 10.1016/s1388-2457(01)00692-7

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  19 in total

1.  Age and sex differences in human motor cortex input-output characteristics.

Authors:  Julia B Pitcher; Kirstin M Ogston; Timothy S Miles
Journal:  J Physiol       Date:  2003-01-15       Impact factor: 5.182

Review 2.  Measures and markers in amyotrophic lateral sclerosis.

Authors:  Merit Cudkowicz; Muhammad Qureshi; Jeremy Shefner
Journal:  NeuroRx       Date:  2004-04

3.  Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study.

Authors:  A Pizzimenti; M Aragona; E Onesti; M Inghilleri
Journal:  Funct Neurol       Date:  2013 Apr-May

Review 4.  Clinical diagnosis and management of amyotrophic lateral sclerosis.

Authors:  Orla Hardiman; Leonard H van den Berg; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

5.  Riluzole blocks human muscle acetylcholine receptors.

Authors:  Cristina Deflorio; Eleonora Palma; Luca Conti; Cristina Roseti; Alessia Manteca; Elena Giacomelli; Myriam Catalano; Cristina Limatola; Maurizio Inghilleri; Francesca Grassi
Journal:  J Physiol       Date:  2012-03-19       Impact factor: 5.182

6.  Analysis of clinical and electrophysiological characteristics of 150 patients with amyotrophic lateral sclerosis in China.

Authors:  Jie Liu; Xuehua Zhang; Xiaojun Ding; Min Song; Kexu Sui
Journal:  Neurol Sci       Date:  2018-11-23       Impact factor: 3.307

Review 7.  Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease.

Authors:  Louisa Ng; Fary Khan; Carolyn A Young; Mary Galea
Journal:  Cochrane Database Syst Rev       Date:  2017-01-10

8.  Speech Movement Measures as Markers of Bulbar Disease in Amyotrophic Lateral Sclerosis.

Authors:  Sanjana Shellikeri; Jordan R Green; Madhura Kulkarni; Panying Rong; Rosemary Martino; Lorne Zinman; Yana Yunusova
Journal:  J Speech Lang Hear Res       Date:  2016-10-01       Impact factor: 2.297

Review 9.  The management of amyotrophic lateral sclerosis.

Authors:  Julie Phukan; Orla Hardiman
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

10.  Interpretation of electrodiagnostic findings in sporadic progressive muscular atrophy.

Authors:  J Visser; M de Visser; R M Van den Berg-Vos; L H Van den Berg; J H J Wokke; J M B V de Jong; H Franssen
Journal:  J Neurol       Date:  2008-05-19       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.